Digraph

2019-06 Columbia and Stanford study on proteasome inhibitors and drug-resistant malaria

Parent topics

This topic

Recent activity

You must be signed in to add and move topics and links.

Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1007722
2019-06 Columbia and Stanford study on proteasome inhibitors and drug-resistant malaria
Drug-Resistant Malaria Cases Increase in Asia : MEDICINE & HEALTH : Science Times
https://www.sciencetimes.com/articles/23469/20190726/drug-resistant-malaria-cases-increase-asia.htm
2019-06 Columbia and Stanford study on proteasome inhibitors and drug-resistant malaria
Proteasome inhibitors show promise for drug-resistant malaria | EurekAlert! Science News
https://www.eurekalert.org/pub_releases/2019-06/p-pis053019.php
2019-06 Columbia and Stanford study on proteasome inhibitors and drug-resistant malaria Drug-resistant malaria